NCT05849506

Brief Summary

The study aims to determine whether CMC I arthroplasty using a Touch® implant results in higher patient satisfaction compared to RSI arthroplasty in the medium-term in patients with primary thumb osteoarthritis. Additionally, the study compares the patients' clinical and self-reported outcomes between the Touch® implant and the RSI arthroplasty. Therefore, patients with a Touch® implant in one thumb and an RSI arthroplasty in the other thumb will be recruited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

June 21, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2024

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

8 months

First QC Date

March 30, 2023

Last Update Submit

April 16, 2024

Conditions

Keywords

Touch® prothesisRSIResection-suspension-interposition arthroplastyThumb carpometacarpal jointDual mobility prosthesis

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction wiht treatment result using 5-point Likert scale

    5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied)

    Follow-up at least 3 months to 12 years after surgery

Secondary Outcomes (9)

  • Sociodemographic information

    Follow-up at least 3 months to 12 years after surgery

  • Additional aspects of patient satisfaction with treatment

    Follow-up at least 3 months to 12 years after surgery

  • Differences between both thumbs

    Follow-up at least 3 months to 12 years after surgery

  • Brief Michigan Hand Outcomes Questionnaire (MHQ)

    Follow-up at least 3 months to 12 years after surgery

  • Grip strength assessed with Jamar Dynamometer

    Follow-up at least 3 months to 12 years after surgery

  • +4 more secondary outcomes

Study Arms (1)

Touch-RSI

The group consists of patients with a Touch® implant in one thumb and an RSI arthroplasty in the other thumb. Intervention: Patient questionnaire and clinical examination to investigate differences between the thumb with a Touch® implant and the thumb with an RSI.

Device: Touch® Prosthesis

Interventions

The Touch® prosthesis is a medical device approved in Switzerland, which is an effective surgical treatment for advanced CMC I osteoarthritis.

Touch-RSI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population consists of patients with CMC I joint osteoarthritis. They have a Touch® prosthesis in one thumb and an RSI arthroplasty in the other.

You may qualify if:

  • Informed Consent signed by the patient.
  • Patient is diagnosed with primary OA in both CMC I joints and was operated with a Touch® prosthesis on one thumb and with an RSI arthroplasty on the other thumb.

You may not qualify if:

  • Patient with any type of revision surgery at the CMC I joint
  • Patient underwent hand surgery within the last three months
  • Legal incompetence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schulthess Klinik

Zurich, 8008, Switzerland

Location

MeSH Terms

Conditions

Joint DiseasesMusculoskeletal DiseasesOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisRheumatic Diseases

Study Officials

  • Daniel B. Herren, Dr. med.

    Schulthess Klinik

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2023

First Posted

May 9, 2023

Study Start

June 21, 2023

Primary Completion

February 10, 2024

Study Completion

February 10, 2024

Last Updated

April 17, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations